IOSAT Potassium Iodide Tablets June 2024 Expiration Date or later
Product Description
There are 14 tablets in each package of iOSAT TM , which will protect one adult for two weeks. Anyone remaining in a contaminated area for more than two weeks should consider the use of additional iOSAT TM tablets as directed by Public Health Officials. New FDA guidelines call for the daily administration of one iOSAT tablet (130 mg. of potassium iodide (KI)) for adults and children over 18 years old who weigh more that 150 pounds. Children from age 3 to 18 years old who weigh less than 150 pounds should take 1/2 tablet. Children from age one month to 3 years should take 1/4 tablet. And infants less than one month old should take 1/4 tablet. If necessary, children too young to take solid food or unable to swallow a tablet can take iOSAT TM dissolved in a liquid (such as chocolate milk) or in a soft food such as applesauce.iOSAT TM Tablets are FDA approved for seven years and should be stored unopened in a dry environment at room temperature. Each iOSAT TM Tablet provides 24 hours of protection. Anbex was formed shortly after the Three Mile Island accident in 1979. The company received its NDA (the FDA approval to sell the product) in 1982 after FDA review of the product and its manufacturing process. The iOSAT TM package comes with a Patient Product Inserted along with the tablets in a sealed package. This was designed so that the instructions would not become separated from the product in times of an emergency. Meets all FDA requirements for potassium iodide as a radiation protective, and is labeled and packaged in accordance with US government guidelines. Has demonstrated all quality controls and passed all FDA requirements for purity, quality, safety, efficacy. Comes full strength (130 mg of potassium iodide per tablet) in accordance with FDA demands for complete thyroid blocking.Feature
This is the newest stock available in the U.S. with an expiration Date of 6/2024